chr1-237591852-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP2BS1_SupportingBS2
The NM_001035.3(RYR2):c.4274C>T(p.Thr1425Met) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.000041 in 1,610,002 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1425A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001035.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RYR2 | ENST00000366574.7 | c.4274C>T | p.Thr1425Met | missense_variant, splice_region_variant | Exon 32 of 105 | 1 | NM_001035.3 | ENSP00000355533.2 | ||
RYR2 | ENST00000609119.2 | n.4274C>T | splice_region_variant, non_coding_transcript_exon_variant | Exon 32 of 104 | 5 | ENSP00000499659.2 | ||||
RYR2 | ENST00000660292.2 | c.4274C>T | p.Thr1425Met | missense_variant, splice_region_variant | Exon 32 of 106 | ENSP00000499787.2 | ||||
RYR2 | ENST00000659194.3 | c.4274C>T | p.Thr1425Met | missense_variant, splice_region_variant | Exon 32 of 105 | ENSP00000499653.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000493 AC: 12AN: 243608Hom.: 0 AF XY: 0.0000378 AC XY: 5AN XY: 132104
GnomAD4 exome AF: 0.0000439 AC: 64AN: 1457870Hom.: 0 Cov.: 30 AF XY: 0.0000469 AC XY: 34AN XY: 725030
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152132Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74304
ClinVar
Submissions by phenotype
not specified Uncertain:2
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Thr1425Me t variant in RYR2 has not been previously reported in individuals with DCM, but has been identified in 1/6884 East Asian chromosomes by the Exome Aggregation Co nsortium (ExAC, http://exac.broadinstitute.org; dbSNP rs761181641). Computationa l prediction tools and conservation analysis suggest that the p.Thr1425Met varia nt may impact the protein, though this information is not predictive enough to d etermine pathogenicity. In summary, the clinical significance of the p.Thr1425Me t variant is uncertain. -
Variant summary: RYR2 c.4274C>T (p.Thr1425Met) results in a non-conservative amino acid change located in the B30.2/SPRY domain (IPR001870) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. Several computational tools predict a significant impact on normal splicing: Three predict the variant weakens a 5' donor site. One predict the variant no significant impact on splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4.9e-05 in 243608 control chromosomes. The observed variant frequency is approximately 2-fold of the estimated maximal expected allele frequency for a pathogenic variant in RYR2 causing Cardiomyopathy phenotype (2.5e-05). Since cardiomyopathy is not necessarily an early onset with high penetrance condition and can often go undiagnosed, this frequency does not allow for any strong conclusion to be made about variant significance. To our knowledge, no occurrence of c.4274C>T in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 505337). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Catecholaminergic polymorphic ventricular tachycardia Uncertain:1
This missense variant replaces threonine with methionine at codon 1425 of the RYR2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 12/243608 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiomyopathy Uncertain:1
This missense variant replaces threonine with methionine at codon 1425 of the RYR2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with RYR2-related disorders in the literature. This variant has been identified in 12/243608 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Catecholaminergic polymorphic ventricular tachycardia 1;C1832931:Arrhythmogenic right ventricular dysplasia 2;C5542154:Ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome Uncertain:1
- -
Catecholaminergic polymorphic ventricular tachycardia 1 Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 1425 of the RYR2 protein (p.Thr1425Met). This variant is present in population databases (rs761181641, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RYR2-related conditions. ClinVar contains an entry for this variant (Variation ID: 505337). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Uncertain:1
The p.T1425M variant (also known as c.4274C>T), located in coding exon 32 of the RYR2 gene, results from a C to T substitution at nucleotide position 4274. The threonine at codon 1425 is replaced by methionine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at